Why the study?
What are the peak plasma concentrations of bupivacaine after axillary block with 2 mg/kg versus 3 mg/kg in children?
What are the peak plasma concentrations of bupivacaine after axillary block with 2 mg/kg versus 3 mg/kg in children?
Bupivacaine doses of 2 mg/kg and 3 mg/kg for axillary block in children result in rapid absorption but produce peak plasma concentrations well below toxic thresholds.
Answers are grounded in this paper and cite their sources.
These subtoxic peaks support cautious dosing in pediatric axillary blocks; leaves open need for randomized safety and efficacy trials.
Venous plasma concentrations of bupivacaine were measured in children following axillary brachial plexus block with either 2 mg/kg (n = 21) or 3 mg/kg (n = 20) of bupivacaine. Absorption was very rapid with a mean time to peak concentrations of 0.37 hours for both doses. Mean peak plasma concentration was 1.35 mg/l after the 2 mg/kg dose and 1.84 mg/kg after the 3 mg/kg dose. Even after a 30% allowance for anticipated higher arterial concentrations, the plasma levels found in the present study were well below those at which toxicity is considered likely (greater than 4 mg/l).
No takes yet. Share an insight, caveat, or question.
Campbell et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: